Dimensional Fund Advisors
TYRA icon

Dimensional Fund Advisors’s Tyra Biosciences TYRA Stock Holding History

Dimensional Fund Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93M Buy
217,078
+125,252
+136% +$4.14M ﹤0.01% 2443
2026
Q1 		$3.52M Sell
91,826
-3,814
-4% -$123K ﹤0.01% 2594
2025
Q4 		$2.51M Buy
95,640
+55,961
+141% +$1.03M ﹤0.01% 2690
2025
Q3 		$555K Sell
39,679
-2,002
-5% -$22.8K ﹤0.01% 2977
2025
Q2 		$399K Buy
41,681
+6,969
+20% +$66.2K ﹤0.01% 3027
2025
Q1 		$323K Sell
34,712
-3,269
-9% -$42.3K ﹤0.01% 3064
2024
Q4 		$528K Buy
37,981
+28,074
+283% +$509K ﹤0.01% 3028
2024
Q3 		$233K Buy
+9,907
New +$208K ﹤0.01% 3145
2024
Q2 		– Sell
-10,750
Closed -$176K – 3412
2024
Q1 		$176K Buy
10,750
+141
+1% +$2.31K ﹤0.01% 3202
2023
Q4 		$147K Hold
10,609
– – ﹤0.01% 3240
2023
Q3 		$146K Buy
10,609
+8
+0.1% +$119 ﹤0.01% 3265
2023
Q2 		$181K Buy
+10,601
New +$154K ﹤0.01% 3252

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Dimensional Fund Advisors's TYRA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Tyra Biosciences (TYRA) stake by 136% in Q2 2026, buying an estimated $4.14M and bringing the position to 217,078 shares worth $6.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

Dimensional Fund Advisors first reported a position in TYRA in Q2 2023 and has held it in 12 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Dimensional Fund Advisors held 217,078 shares of Tyra Biosciences worth $6.93M as of Q2 2026.
  • Dimensional Fund Advisors bought 125,252 Tyra Biosciences shares in Q2 2026, an estimated $4.14M.
  • Tyra Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2443 holding.
  • Dimensional Fund Advisors first reported a position in Tyra Biosciences in Q2 2023 and has held it in 12 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.